LIMES Schlosskliniken AG (ETR:LIK)

Market Cap	169.83M +66.5%
Revenue (ttm)	50.00M +33.5%
Net Income	5.69M +83.0%
EPS	19.11 +80.1%
Shares Out	297.95K
PE Ratio	29.82
Forward PE	16.01
Dividend	10.00 (1.74%)
Ex-Dividend Date	Jun 22, 2026

Volume	1
Open	575.00
Previous Close	570.00
Day's Range	575.00 - 575.00
52-Week Range	316.00 - 595.00
Beta	0.88
Analysts	Strong Buy
Price Target	697.50 (+21.3%)
Earnings Date	Sep 3, 2026

About LIMES Schlosskliniken AG

LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, Italy, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2005
• Employees: 346
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: LIK

Financial Performance

In 2025, LIMES Schlosskliniken AG's revenue was 50.00 million, an increase of 33.49% compared to the previous year's 37.45 million. Earnings were 5.69 million, an increase of 83.01%.

Analyst Summary

According to 2 analysts, the average rating for LIK stock is "Strong Buy." The 12-month stock price target is €697.50, which is an increase of 21.30% from the latest price.

Price Target

€697.50

(21.30% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error